Novo Holdings A/S - Q4 2020 holdings

Add to watchlist

$2.33 Billion is the total value of Novo Holdings A/S's 45 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 31.0% .

All
New
Buy
Sell
Exit
Unchanged
 Value Shares↓ Weighting
VTI SellVANGUARD INDEX FDStotal stk mkt$376,414,000
-28.0%
1,933,900
-37.0%
16.14%
-37.8%
NKTX  NKARTA INC$171,739,000
+104.5%
2,793,8640.0%7.36%
+76.6%
INGN  INOGEN INC$158,584,000
+54.1%
3,549,3200.0%6.80%
+33.1%
AAPL SellAPPLE INC$137,653,000
-5.1%
1,037,404
-17.1%
5.90%
-18.0%
PRAX NewPRAXIS PRECISION MEDICINES I$134,363,000–2,442,080
+100.0%
5.76%–
HRMY SellHARMONY BIOSCIENCES HLDGS IN$130,952,000
+2.9%
3,622,471
-3.5%
5.61%
-11.2%
BAM  BROOKFIELD ASSET MGMT INCcl a ltd vt sh$126,738,000
+24.8%
3,070,9570.0%5.43%
+7.8%
SPRB NewSPRUCE BIOSCIENCES INC$121,291,000–4,989,336
+100.0%
5.20%–
CABO SellCABLE ONE INC$116,601,000
+7.9%
52,341
-8.6%
5.00%
-6.8%
CTLT SellCATALENT INC$103,794,000
-25.5%
997,349
-38.7%
4.45%
-35.6%
MORF  MORPHIC HLDG INC$88,755,000
+22.7%
2,645,4460.0%3.80%
+6.0%
ALGS NewALIGOS THERAPEUTICS INC$72,293,000–2,614,563
+100.0%
3.10%–
INZY  INOZYME PHARMA INC$53,032,000
-21.5%
2,569,3790.0%2.27%
-32.2%
FRLN BuyFREELINE THERAPEUTICS HLDGSsponsored ads$43,116,000
+315.3%
2,361,229
+255.1%
1.85%
+258.8%
MIRM  MIRUM PHARMACEUTICALS INC$42,692,000
-9.4%
2,445,1470.0%1.83%
-21.8%
FOLD SellAMICUS THERAPEUTICS INC$38,902,000
+18.8%
1,684,795
-27.4%
1.67%
+2.6%
EAR NewEARGO INC$33,036,000–737,071
+100.0%
1.42%–
CMPI  CHECKMATE PHARMACEUTICALS IN$31,662,000
+26.8%
2,170,1000.0%1.36%
+9.4%
GLTO NewGALECTO INC$31,247,000–2,497,791
+100.0%
1.34%–
GRTX SellGALERA THERAPEUTICS INC$30,271,000
-1.8%
2,959,021
-13.2%
1.30%
-15.2%
SPNE SellSEASPINE HLDGS CORP$23,367,000
-2.6%
1,339,085
-20.2%
1.00%
-15.9%
BPMC SellBLUEPRINT MEDICINES CORP$22,094,000
+1.4%
197,000
-16.2%
0.95%
-12.4%
VRNA BuyVERONA PHARMA PLCsponsored ads$18,261,000
+62.5%
2,608,755
+44.9%
0.78%
+40.3%
IOVA SellIOVANCE BIOTHERAPEUTICS INC$17,823,000
+40.6%
384,117
-0.2%
0.76%
+21.5%
PTGX BuyPROTAGONIST THERAPEUTICS INC$17,493,000
+12.6%
867,724
+9.2%
0.75%
-2.7%
CNST BuyCONSTELLATION PHARMCETICLS I$17,250,000
+47.3%
598,951
+3.6%
0.74%
+27.4%
MIST BuyMILESTONE PHARMACEUTICALS IN$16,955,000
+11.3%
2,530,585
+21.6%
0.73%
-3.8%
FLXN  FLEXION THERAPEUTICS INC$16,195,000
+10.9%
1,403,3700.0%0.69%
-4.3%
INSM  INSMED INC$14,318,000
+3.6%
430,1070.0%0.61%
-10.5%
LUNG NewPULMONX CORP$12,910,000–187,047
+100.0%
0.55%–
KNTE NewKINNATE BIOPHARMA INC$11,934,000–300,000
+100.0%
0.51%–
XENT SellINTERSECT ENT INC$11,501,000
+37.3%
502,225
-2.2%
0.49%
+18.5%
SPRO SellSPERO THERAPEUTICS INC$11,182,000
+7.6%
576,702
-38.1%
0.48%
-7.2%
PCVX SellVAXCYTE INC$11,078,000
-65.6%
416,937
-36.0%
0.48%
-70.2%
AERI  AERIE PHARMACEUTICALS INC$10,911,000
+14.8%
807,6560.0%0.47%
-0.8%
AKUS BuyAKOUOS INC$9,108,000
-13.2%
459,290
+0.1%
0.39%
-25.1%
INSP SellINSPIRE MED SYS INC$7,524,000
-2.2%
40,000
-32.9%
0.32%
-15.4%
AFIB  ACTUS MED INC$7,347,000
-3.3%
255,0000.0%0.32%
-16.4%
BHVN SellBIOHAVEN PHARMACTL HLDG CO L$7,123,000
+29.5%
83,100
-1.8%
0.30%
+11.7%
ZGNX  ZOGENIX INC$6,513,000
+11.5%
325,8140.0%0.28%
-3.8%
NARI SellINARI MED INC$6,303,000
+21.0%
72,212
-4.4%
0.27%
+4.2%
SILK SellSILK RD MED INC$5,045,000
-40.2%
80,102
-36.1%
0.22%
-48.3%
CRNX  CRINETICS PHARMACEUTICALS IN$3,829,000
-9.9%
271,3780.0%0.16%
-22.3%
CRVS SellCORVUS PHARMACEUTICALS INC$3,019,000
-45.8%
847,906
-39.0%
0.13%
-53.4%
FSTX NewF-STAR THERAPEUTICS INC$344,000–34,819
+100.0%
0.02%–
ETTX ExitENTASIS THERAPEUTICS HLDGS I$0–-1,153,911
-100.0%
-0.12%–
AKBA ExitAKEBIA THERAPEUTICS INC$0–-1,987,506
-100.0%
-0.25%–
CVAC ExitCUREVAC N V$0–-201,642
-100.0%
-0.47%–
SIBN ExitSI BONE INC$0–-698,504
-100.0%
-0.82%–
MDT ExitMEDTRONIC PLC$0–-988,136
-100.0%
-5.10%–
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-02-16
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
VANGUARD INDEX FDS41Q3 202264.7%
INOGEN INC34Q2 202268.8%
VANGUARD INTL EQUITY INDEX F29Q4 201637.6%
AMICUS THERAPEUTICS INC22Q3 20234.1%
AKEBIA THERAPEUTICS INC21Q3 20204.8%
VERONA PHARMA PLC21Q2 20221.9%
CORVUS PHARMACEUTICALS INC20Q4 20207.1%
INSPIRE MED SYS INC20Q3 20231.8%
CABLE ONE INC19Q3 20239.7%
FLEXION THERAPEUTICS INC19Q3 20214.7%

View Novo Holdings A/S's complete holdings history.

Latest significant ownerships (13-D/G)
Novo Holdings A/S Q4 2020 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Cyteir Therapeutics, Inc.August 03, 20231,547,1364.4%
Disc Medicine, Inc.June 28, 20231,090,7724.8%
Galera Therapeutics, Inc.June 28, 20232,100,0004.9%
VectivBio Holding AGSold outMay 26, 202300.0%
LanzaTech Global, Inc.February 17, 202315,814,8458.1%
Bolt Biotherapeutics, Inc.Sold outJanuary 04, 202300.0%
Arcellx, Inc.December 12, 20221,750,0004.0%
MINERVA SURGICAL INCNovember 03, 20221,322,4734.5%
Milestone Pharmaceuticals Inc.October 24, 20221,378,5384.6%
Galecto, Inc.September 30, 20222,497,7919.8%

View Novo Holdings A/S's complete significant-ownership history.

Latest filings
TypeFiled
SC 13D/A2024-03-28
42024-03-25
SC 13D/A2024-03-25
42024-03-20
SC 13D/A2024-03-20
1442024-03-18
42024-03-18
SC 13D/A2024-03-18
1442024-03-14
SC 13D/A2024-03-07

View Novo Holdings A/S's complete filings history.

All filings

View complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (2332560000.0 != 2332562000.0)

Export Novo Holdings A/S's holdings

CSVXLS